With more outsourcing, more stakeholders, more regulatory requirements, more financial investments.., the overall complexity of a life sciences company is increasing significantly. From a governance point of view this means that appropriate risk management should be implemented to maintain operational efficiency and financial integrity in order to guarantee the highest security and privacy standards, comply with regulatory requirements and, last but not least, cope with technological challenges.
In order to face these challenges, most companies will need to focus on:
Deloitte provides life sciences companies with a broad range of services surrounding governance and enterprise-wide risk management: